Skip to main content
Top
Published in:

Open Access 06-11-2024 | Pituitary Apoplexy | Review

The role of intervention timing and treatment modality in visual recovery following pituitary apoplexy: a systematic review and meta-analysis

Authors: Nolan J. Brown, Saarang Patel, Julian Gendreau, Mickey E. Abraham

Published in: Journal of Neuro-Oncology | Issue 3/2024

Login to get access

Abstract

Introduction

Pituitary apoplexy has historically been considered an emergent condition that necessitates surgical intervention when there is acute symptomatic onset. This potentially serious condition often occurs in the setting of an underlying adenoma, cystic lesion, or other sellar mass. When these mass lesions hemorrhage within the confined space of the sella turcica, the pituitary gland is subjected to hemorrhagic ischemia. Furthermore, critical neurovasculature in close proximity to the sella can sustain collateral damage. In the present study, we investigate whether early versus delayed surgical intervention (in terms of three timelines: before versus after 48 h, 72 h, and 7 days, respectively) results in differences in visual outcomes for patients experiencing pituitary apoplexy with acute onset neurological and/or neuro-opthalmic symptoms. Furthermore, we compare the efficacy of surgical decompression versus expectant management of this condition.

Methods

Accordingly, we queried the PubMed, Scopus, and Embase databases in adherence to PRISMA guidelines. Quantitative meta-analysis was performed according to the Mantel–Haenszel method and forest plots were generated using Review Manager v5.4. P-values < 0.05 were defined as the threshold for statistical significance.

Results

Twenty-nine studies remained eligible for review following initial search and screen, including 16 studies describing the role of intervention timing and 15 studies comparing intervention modality. Most patients presented with a visual deficit, and all patients underwent surgery – most commonly via the endoscopic endonasal (EEA) approach. Two hundred and twenty patients were included in the sub-analysis for the 7-day cutoff point. Furthermore, 81 patients underwent surgical decompression of the sella prior to 48 h, and 32 patients underwent surgical decompression between 48–72 h following presentation. Almost all patients exhibited improved vision post-decompression, including 19/19 patients (100%) in the post-72-h cohort. On meta-analysis using the Mantel–Haenszel method, there was a significant difference in vision outcomes in favor of patients who underwent surgical decompression before 7 days as compared to after seven days (OR 5.88, 95% CI [1.77, 19.60], I2 = 0%, p < 0.01). In a separate sub-analysis, there was a total of 288 patients across 15 studies comparing surgical versus conservative management of pituitary apoplexy. These management options proved equivocal on meta-analysis (p > 0.05).

Conclusion

In the present study, timing of surgical intervention for pituitary apoplexy was predictive of visual function recovery only at the 7-day timepoint, as has been reported by previous studies. Ultimately, this suggests that pituitary apoplexy involving severe visual deficits or altered mental status is best addressed within the first seven days post-presentation, and that both surgery and conservative management can offer similar outcomes. When apoplexy is suspected, IV corticosteroids should be administered independent of acuity or severity to prevent secondary adrenal crisis. Subsequently, for patients presenting without severe visual or other neurological deficits, expectant management is recommended. Management should be patient-specific and dependent upon the severity of symptoms present at onset.
Literature
1.
go back to reference Abdulbaki A, Kanaan I (2017) The impact of surgical timing on visual outcome in pituitary apoplexy: Literature review and case illustration. Surg Neurol Int 8(1):16PubMedPubMedCentralCrossRef Abdulbaki A, Kanaan I (2017) The impact of surgical timing on visual outcome in pituitary apoplexy: Literature review and case illustration. Surg Neurol Int 8(1):16PubMedPubMedCentralCrossRef
2.
go back to reference Greenberg MS (2019) Handbook of Neurosurgery, 9th ed. Thieme Medical Greenberg MS (2019) Handbook of Neurosurgery, 9th ed. Thieme Medical
3.
4.
go back to reference Maccagnan P, Macedo CL, Kayath MJ, Nogueira RG, Abucham J (1995) Conservative management of pituitary apoplexy: a prospective study. J Clin Endocrinol Metab 80(7):2190–2197PubMed Maccagnan P, Macedo CL, Kayath MJ, Nogueira RG, Abucham J (1995) Conservative management of pituitary apoplexy: a prospective study. J Clin Endocrinol Metab 80(7):2190–2197PubMed
5.
go back to reference Gruber A, Clayton J, Kumar S, Robertson I, Howlett TA, Mansell P (2006) Pituitary apoplexy: retrospective review of 30 patients–is surgical intervention always necessary? Br J Neurosurg 20(6):379–385PubMedCrossRef Gruber A, Clayton J, Kumar S, Robertson I, Howlett TA, Mansell P (2006) Pituitary apoplexy: retrospective review of 30 patients–is surgical intervention always necessary? Br J Neurosurg 20(6):379–385PubMedCrossRef
6.
go back to reference Dubuisson AS, Beckers A, Stevenaert A (2007) Classical pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patients. Clin Neurol Neurosurg 109(1):63–70PubMedCrossRef Dubuisson AS, Beckers A, Stevenaert A (2007) Classical pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patients. Clin Neurol Neurosurg 109(1):63–70PubMedCrossRef
7.
go back to reference Shepard MJ, Snyder MH, Soldozy S, Ampie LL, Morales-Valero SF, Jane JA (2021) Radiological and clinical outcomes of pituitary apoplexy: comparison of conservative management versus early surgical intervention. J Neurosurg 135(5):1310–1318PubMedCrossRef Shepard MJ, Snyder MH, Soldozy S, Ampie LL, Morales-Valero SF, Jane JA (2021) Radiological and clinical outcomes of pituitary apoplexy: comparison of conservative management versus early surgical intervention. J Neurosurg 135(5):1310–1318PubMedCrossRef
8.
go back to reference Singh TD, Valizadeh N, Meyer FB, Atkinson JLD, Erickson D, Rabinstein AA (2015) Management and outcomes of pituitary apoplexy. J Neurosurg 122(6):1450–1457PubMedCrossRef Singh TD, Valizadeh N, Meyer FB, Atkinson JLD, Erickson D, Rabinstein AA (2015) Management and outcomes of pituitary apoplexy. J Neurosurg 122(6):1450–1457PubMedCrossRef
9.
go back to reference Kelly PD, Fernando SJ, Malenke JA, Chandra RK, Turner JH, Chambless LB (2021) The effect of timing of surgery in pituitary apoplexy on continuously valued visual acuity. J Neurol Surg B Skull Base 82(Suppl 3):e70–e78PubMed Kelly PD, Fernando SJ, Malenke JA, Chandra RK, Turner JH, Chambless LB (2021) The effect of timing of surgery in pituitary apoplexy on continuously valued visual acuity. J Neurol Surg B Skull Base 82(Suppl 3):e70–e78PubMed
10.
go back to reference Bills DC, Meyer FB, Laws ER Jr et al (1993) A retrospective analysis of pituitary apoplexy. Neurosurgery 33(4):602–609PubMed Bills DC, Meyer FB, Laws ER Jr et al (1993) A retrospective analysis of pituitary apoplexy. Neurosurgery 33(4):602–609PubMed
11.
go back to reference Sibal L, Ball SG, Connolly V et al (2004) Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases. Pituitary 7(3):157–163PubMedCrossRef Sibal L, Ball SG, Connolly V et al (2004) Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases. Pituitary 7(3):157–163PubMedCrossRef
12.
go back to reference Chuang CC, Chang CN, Wei KC et al (2006) Surgical treatment for severe visual compromised patients after pituitary apoplexy. J Neurooncol 80(1):39–47PubMedCrossRef Chuang CC, Chang CN, Wei KC et al (2006) Surgical treatment for severe visual compromised patients after pituitary apoplexy. J Neurooncol 80(1):39–47PubMedCrossRef
13.
go back to reference Muthukumar N, Rossette D, Soundaram M, Senthilbabu S, Badrinarayanan T (2008) Blindness following pituitary apoplexy: timing of surgery and neuro-ophthalmic outcome. J Clin Neurosci 15(8):873–879PubMedCrossRef Muthukumar N, Rossette D, Soundaram M, Senthilbabu S, Badrinarayanan T (2008) Blindness following pituitary apoplexy: timing of surgery and neuro-ophthalmic outcome. J Clin Neurosci 15(8):873–879PubMedCrossRef
14.
go back to reference Takeda N, Fujita K, Katayama S, Akutu N, Hayashi S, Kohmura E (2010) Effect of transsphenoidal surgery on decreased visual acuity caused by pituitary apoplexy. Pituitary 13(2):154–159PubMedCrossRef Takeda N, Fujita K, Katayama S, Akutu N, Hayashi S, Kohmura E (2010) Effect of transsphenoidal surgery on decreased visual acuity caused by pituitary apoplexy. Pituitary 13(2):154–159PubMedCrossRef
15.
go back to reference Woo HJ, Hwang JH, Hwang SK, Park YM (2010) Clinical outcome of cranial neuropathy in patients with pituitary apoplexy. J Korean Neurosurg Soc 48(3):213–218PubMedPubMedCentralCrossRef Woo HJ, Hwang JH, Hwang SK, Park YM (2010) Clinical outcome of cranial neuropathy in patients with pituitary apoplexy. J Korean Neurosurg Soc 48(3):213–218PubMedPubMedCentralCrossRef
16.
go back to reference Seuk JW, Kim CH, Yang MS, Cheong JH, Kim JM (2011) Visual outcome after transsphenoidal surgery in patients with pituitary apoplexy. J Korean Neurosurg Soc 49(6):339–344PubMedPubMedCentralCrossRef Seuk JW, Kim CH, Yang MS, Cheong JH, Kim JM (2011) Visual outcome after transsphenoidal surgery in patients with pituitary apoplexy. J Korean Neurosurg Soc 49(6):339–344PubMedPubMedCentralCrossRef
17.
go back to reference Giritharan S, Gnanalingham K, Kearney T (2016) Pituitary apoplexy - bespoke patient management allows good clinical outcome. Clin Endocrinol (Oxf) 85(3):415–422PubMedCrossRef Giritharan S, Gnanalingham K, Kearney T (2016) Pituitary apoplexy - bespoke patient management allows good clinical outcome. Clin Endocrinol (Oxf) 85(3):415–422PubMedCrossRef
18.
go back to reference Rutkowski M, Kunwar S, Blevins L, Aghi M (2017) Neuroendocrinological outcomes following early versus delayed surgery for acute pituitary apoplexy. J Neurol Surg B Skull Base 78(S01):S1–S156 Rutkowski M, Kunwar S, Blevins L, Aghi M (2017) Neuroendocrinological outcomes following early versus delayed surgery for acute pituitary apoplexy. J Neurol Surg B Skull Base 78(S01):S1–S156
19.
go back to reference Seo Y, Kim YH, Dho YS et al (2018) The outcomes of pituitary apoplexy with conservative treatment: Experiences at a single institution. World Neurosurg 115:e703–e710PubMedCrossRef Seo Y, Kim YH, Dho YS et al (2018) The outcomes of pituitary apoplexy with conservative treatment: Experiences at a single institution. World Neurosurg 115:e703–e710PubMedCrossRef
20.
go back to reference Cabuk B, Kaya NS, Polat C et al (2021) Outcome in pituitary apoplexy patients, stratified by delay between symptom appearance and surgery: A single center retrospective analysis. Clin Neurol Neurosurg 210(106991):106991PubMedCrossRef Cabuk B, Kaya NS, Polat C et al (2021) Outcome in pituitary apoplexy patients, stratified by delay between symptom appearance and surgery: A single center retrospective analysis. Clin Neurol Neurosurg 210(106991):106991PubMedCrossRef
21.
go back to reference McFadzean RM, Doyle D, Rampling R, Teasdale E, Teasdale G (1991) Pituitary apoplexy and its effect on vision. Neurosurgery 29(5):669–675PubMedCrossRef McFadzean RM, Doyle D, Rampling R, Teasdale E, Teasdale G (1991) Pituitary apoplexy and its effect on vision. Neurosurgery 29(5):669–675PubMedCrossRef
23.
go back to reference Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJL (2004) Acute management of pituitary apoplexy–surgery or conservative management? Clin Endocrinol (Oxf) 61(6):747–752PubMedCrossRef Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJL (2004) Acute management of pituitary apoplexy–surgery or conservative management? Clin Endocrinol (Oxf) 61(6):747–752PubMedCrossRef
24.
go back to reference Leyer C, Castinetti F, Morange I et al (2011) A conservative management is preferable in milder forms of pituitary tumor apoplexy. J Endocrinol Invest 34(7):502–509PubMed Leyer C, Castinetti F, Morange I et al (2011) A conservative management is preferable in milder forms of pituitary tumor apoplexy. J Endocrinol Invest 34(7):502–509PubMed
25.
go back to reference Simon S, Torpy D, Brophy B, Blumbergs P, Selva D, Crompton JL (2011) Neuro-ophthalmic manifestations and outcomes of pituitary apoplexy–a life and sight-threatening emergency. N Z Med J 124(1335):52–59PubMed Simon S, Torpy D, Brophy B, Blumbergs P, Selva D, Crompton JL (2011) Neuro-ophthalmic manifestations and outcomes of pituitary apoplexy–a life and sight-threatening emergency. N Z Med J 124(1335):52–59PubMed
26.
go back to reference Marx C, Rabilloud M, BorsonChazot F, Tilikete C, Jouanneau E, Raverot G (2021) A key role for conservative treatment in the management of pituitary apoplexy. Endocrine 71(1):168–177PubMedCrossRef Marx C, Rabilloud M, BorsonChazot F, Tilikete C, Jouanneau E, Raverot G (2021) A key role for conservative treatment in the management of pituitary apoplexy. Endocrine 71(1):168–177PubMedCrossRef
27.
go back to reference Budohoski KP, Khawari S, Cavalli A et al (2022) Long-term oncological outcomes after haemorrhagic apoplexy in pituitary adenoma managed operatively and non-operatively. Acta Neurochir (Wien) 164(4):1115–1123PubMedCrossRef Budohoski KP, Khawari S, Cavalli A et al (2022) Long-term oncological outcomes after haemorrhagic apoplexy in pituitary adenoma managed operatively and non-operatively. Acta Neurochir (Wien) 164(4):1115–1123PubMedCrossRef
28.
go back to reference Bujawansa S, Thondam SK, Steele C et al (2014) Presentation, management and outcomes in acute pituitary apoplexy: a large single-centre experience from the United Kingdom. Clin Endocrinol (Oxf) 80(3):419–424PubMedCrossRef Bujawansa S, Thondam SK, Steele C et al (2014) Presentation, management and outcomes in acute pituitary apoplexy: a large single-centre experience from the United Kingdom. Clin Endocrinol (Oxf) 80(3):419–424PubMedCrossRef
29.
go back to reference Okada H, Kodama N, Mineura K, Sakamoto T, Suzuki J (1980) A ruptured aneurysm associated with pituitary tumor (author’s transl). No Shinkei Geka 8(4):379–381PubMed Okada H, Kodama N, Mineura K, Sakamoto T, Suzuki J (1980) A ruptured aneurysm associated with pituitary tumor (author’s transl). No Shinkei Geka 8(4):379–381PubMed
30.
go back to reference Fujiwara S, Fujii K, Nishio S, Fukui M (1991) Diagnosis and treatment of pituitary adenoma with adjacent carotid artery aneurysm. J Neurosurg Sci 35(1):41–46PubMed Fujiwara S, Fujii K, Nishio S, Fukui M (1991) Diagnosis and treatment of pituitary adenoma with adjacent carotid artery aneurysm. J Neurosurg Sci 35(1):41–46PubMed
31.
go back to reference Jordan RM, Kerber CW (1978) Rupture of a parasellar aneurysm with a coexisting pituitary tumor. South Med J 71(6):741–742PubMedCrossRef Jordan RM, Kerber CW (1978) Rupture of a parasellar aneurysm with a coexisting pituitary tumor. South Med J 71(6):741–742PubMedCrossRef
32.
go back to reference Pant B, Arita K, Kurisu K, Tominaga A, Eguchi K, Uozumi T (1997) Incidence of intracranial aneurysm associated with pituitary adenoma. Neurosurg Rev 20(1):13–17PubMedCrossRef Pant B, Arita K, Kurisu K, Tominaga A, Eguchi K, Uozumi T (1997) Incidence of intracranial aneurysm associated with pituitary adenoma. Neurosurg Rev 20(1):13–17PubMedCrossRef
33.
go back to reference Laidlaw JD, Tress B, Gonzales MF, Wray AC, Ng WH, O’Brien JM (2003) Coexistence of aneurysmal subarachnoid haemorrhage and pituitary apoplexy: Case report and review of the literature. J Clin Neurosci 10(4):478–482PubMedCrossRef Laidlaw JD, Tress B, Gonzales MF, Wray AC, Ng WH, O’Brien JM (2003) Coexistence of aneurysmal subarachnoid haemorrhage and pituitary apoplexy: Case report and review of the literature. J Clin Neurosci 10(4):478–482PubMedCrossRef
34.
35.
go back to reference Song RX, Wang DK, Wang Z et al (2014) Coexistence of aneurysmal subarachnoid hemorrhage and surgically identified pituitary apoplexy: a case report and review of the literature. J Med Case Rep 8(1):166PubMedPubMedCentralCrossRef Song RX, Wang DK, Wang Z et al (2014) Coexistence of aneurysmal subarachnoid hemorrhage and surgically identified pituitary apoplexy: a case report and review of the literature. J Med Case Rep 8(1):166PubMedPubMedCentralCrossRef
36.
go back to reference Xu K, Yuan Y, Zhou J, Yu J (2015) Pituitary adenoma apoplexy caused by rupture of an anterior communicating artery aneurysm: case report and literature review. World J Surg Oncol 13(1):228PubMedPubMedCentralCrossRef Xu K, Yuan Y, Zhou J, Yu J (2015) Pituitary adenoma apoplexy caused by rupture of an anterior communicating artery aneurysm: case report and literature review. World J Surg Oncol 13(1):228PubMedPubMedCentralCrossRef
37.
go back to reference Shahlaie K, Olaya JE, Hartman J, Watson JC (2006) Pituitary apoplexy associated with anterior communicating artery aneurysm and aberrant blood supply. J Clin Neurosci 13(10):1057–1062PubMedCrossRef Shahlaie K, Olaya JE, Hartman J, Watson JC (2006) Pituitary apoplexy associated with anterior communicating artery aneurysm and aberrant blood supply. J Clin Neurosci 13(10):1057–1062PubMedCrossRef
38.
go back to reference Kim YH, Cho YH, Hong SH et al (2018) Postoperative neurologic outcome in patients with pituitary apoplexy after transsphenoidal surgery. World Neurosurg 111:e18–e23PubMedCrossRef Kim YH, Cho YH, Hong SH et al (2018) Postoperative neurologic outcome in patients with pituitary apoplexy after transsphenoidal surgery. World Neurosurg 111:e18–e23PubMedCrossRef
39.
go back to reference Lee J, Hwang SC, Park ST (2023) Pituitary apoplexy after leuprolide therapy in a breast cancer patient: A case report. Brain Tumor Res Treat 11(2):153–157PubMedPubMedCentralCrossRef Lee J, Hwang SC, Park ST (2023) Pituitary apoplexy after leuprolide therapy in a breast cancer patient: A case report. Brain Tumor Res Treat 11(2):153–157PubMedPubMedCentralCrossRef
40.
go back to reference Muthukumar N (2020) Pituitary apoplexy: A comprehensive review. Neurol India 68(Supplement):S72–S78PubMedCrossRef Muthukumar N (2020) Pituitary apoplexy: A comprehensive review. Neurol India 68(Supplement):S72–S78PubMedCrossRef
41.
go back to reference Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA (1999) Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf) 51(2):181–188PubMedCrossRef Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA (1999) Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf) 51(2):181–188PubMedCrossRef
42.
go back to reference Agrawal D, Mahapatra AK (2005) Visual outcome of blind eyes in pituitary apoplexy after transsphenoidal surgery: a series of 14 eyes. Surg Neurol. 63(1):42–46 (discussion 46)PubMedCrossRef Agrawal D, Mahapatra AK (2005) Visual outcome of blind eyes in pituitary apoplexy after transsphenoidal surgery: a series of 14 eyes. Surg Neurol. 63(1):42–46 (discussion 46)PubMedCrossRef
43.
go back to reference Culpin E, Crank M, Igra M et al (2018) Pituitary tumour apoplexy within prolactinomas in children: a more aggressive condition? Pituitary 21(5):474–479PubMedPubMedCentralCrossRef Culpin E, Crank M, Igra M et al (2018) Pituitary tumour apoplexy within prolactinomas in children: a more aggressive condition? Pituitary 21(5):474–479PubMedPubMedCentralCrossRef
44.
go back to reference Sahyouni R, Goshtasbi K, Choi E et al (2019) Vision outcomes in early versus late surgical intervention of pituitary apoplexy: Meta-analysis. World Neurosurg 127:52–57PubMedCrossRef Sahyouni R, Goshtasbi K, Choi E et al (2019) Vision outcomes in early versus late surgical intervention of pituitary apoplexy: Meta-analysis. World Neurosurg 127:52–57PubMedCrossRef
45.
go back to reference Little AS, Mooney MA (2019) eds. 16 surgery versus medical management: First-line treatment for pituitary apoplexy. In: Controversies in Skull Base Surgery. Georg Thieme Verlag Little AS, Mooney MA (2019) eds. 16 surgery versus medical management: First-line treatment for pituitary apoplexy. In: Controversies in Skull Base Surgery. Georg Thieme Verlag
47.
go back to reference Pelkonen R, Kuusisto A, Salmi J et al (1978) Pituitary function after pituitary apoplexy. Am J Med 65(5):773–778PubMedCrossRef Pelkonen R, Kuusisto A, Salmi J et al (1978) Pituitary function after pituitary apoplexy. Am J Med 65(5):773–778PubMedCrossRef
48.
go back to reference Vanderpump M, Higgens C, Wass JAH (2011) UK guidelines for the management of pituitary apoplexy a rare but potentially fatal medical emergency. Emerg Med J 28(7):550–551PubMedCrossRef Vanderpump M, Higgens C, Wass JAH (2011) UK guidelines for the management of pituitary apoplexy a rare but potentially fatal medical emergency. Emerg Med J 28(7):550–551PubMedCrossRef
49.
go back to reference Onesti ST, Wisniewski T, Post KD (1990) Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and outcome in 21 patients. Neurosurgery 26(6):980–986PubMedCrossRef Onesti ST, Wisniewski T, Post KD (1990) Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and outcome in 21 patients. Neurosurgery 26(6):980–986PubMedCrossRef
50.
51.
go back to reference Semple PL, Jane JA Jr, Laws ER Jr (2007) Clinical relevance of precipitating factors in pituitary apoplexy. Neurosurgery 61(5):956–961 (discussion 961–2)PubMedCrossRef Semple PL, Jane JA Jr, Laws ER Jr (2007) Clinical relevance of precipitating factors in pituitary apoplexy. Neurosurgery 61(5):956–961 (discussion 961–2)PubMedCrossRef
52.
go back to reference Zayour DH, Selman WR, Arafah BM (2004) Extreme elevation of intrasellar pressure in patients with pituitary tumor apoplexy: relation to pituitary function. J Clin Endocrinol Metab 89(11):5649–5654PubMedCrossRef Zayour DH, Selman WR, Arafah BM (2004) Extreme elevation of intrasellar pressure in patients with pituitary tumor apoplexy: relation to pituitary function. J Clin Endocrinol Metab 89(11):5649–5654PubMedCrossRef
53.
go back to reference Lubina A, Olchovsky D, Berezin M, Ram Z, Hadani M, Shimon I (2005) Management of pituitary apoplexy: clinical experience with 40 patients. Acta Neurochir (Wien). 147(2):151–157 (discussion 157)PubMedCrossRef Lubina A, Olchovsky D, Berezin M, Ram Z, Hadani M, Shimon I (2005) Management of pituitary apoplexy: clinical experience with 40 patients. Acta Neurochir (Wien). 147(2):151–157 (discussion 157)PubMedCrossRef
54.
go back to reference Briet C, Salenave S, Bonneville JF, Laws ER, Chanson P (2015) Pituitary apoplexy. Endocr Rev 36(6):622–645PubMedCrossRef Briet C, Salenave S, Bonneville JF, Laws ER, Chanson P (2015) Pituitary apoplexy. Endocr Rev 36(6):622–645PubMedCrossRef
55.
go back to reference Reddy NL, Rajasekaran S, Han TS et al (2011) An objective scoring tool in the management of patients with pituitary apoplexy. Clin Endocrinol (Oxf) 75(5):723PubMedCrossRef Reddy NL, Rajasekaran S, Han TS et al (2011) An objective scoring tool in the management of patients with pituitary apoplexy. Clin Endocrinol (Oxf) 75(5):723PubMedCrossRef
56.
go back to reference Goshtasbi K, Abiri A, Sahyouni R et al (2019) Visual and endocrine recovery following conservative and surgical treatment of pituitary apoplexy: A meta-analysis. World Neurosurg 132:33–40PubMedCrossRef Goshtasbi K, Abiri A, Sahyouni R et al (2019) Visual and endocrine recovery following conservative and surgical treatment of pituitary apoplexy: A meta-analysis. World Neurosurg 132:33–40PubMedCrossRef
57.
go back to reference Wang L, Long S, Zhou Q (2022) Letter to the Editor Treatment for pituitary apoplexy. J Neurosurg 136(6):1812PubMedCrossRef Wang L, Long S, Zhou Q (2022) Letter to the Editor Treatment for pituitary apoplexy. J Neurosurg 136(6):1812PubMedCrossRef
58.
go back to reference Tu M, Lu Q, Zhu P, Zheng W (2016) Surgical versus non-surgical treatment for pituitary apoplexy: A systematic review and meta-analysis. J Neurol Sci 370:258–262PubMedCrossRef Tu M, Lu Q, Zhu P, Zheng W (2016) Surgical versus non-surgical treatment for pituitary apoplexy: A systematic review and meta-analysis. J Neurol Sci 370:258–262PubMedCrossRef
59.
go back to reference Nakhleh A, AssaliyaNaffa M, Sviri G, Shehadeh N, Hochberg I (2021) Outcomes of pituitary apoplexy: a comparison of microadenomas and macroadenomas. Pituitary 24(4):492–498PubMedCrossRef Nakhleh A, AssaliyaNaffa M, Sviri G, Shehadeh N, Hochberg I (2021) Outcomes of pituitary apoplexy: a comparison of microadenomas and macroadenomas. Pituitary 24(4):492–498PubMedCrossRef
60.
go back to reference Jho DH, Biller BMK, Agarwalla PK, Swearingen B (2014) Pituitary apoplexy: large surgical series with grading system. World Neurosurg 82(5):781–790PubMedCrossRef Jho DH, Biller BMK, Agarwalla PK, Swearingen B (2014) Pituitary apoplexy: large surgical series with grading system. World Neurosurg 82(5):781–790PubMedCrossRef
61.
go back to reference Zhang F, Chen J, Lu Y, Ding X (2009) Manifestation, management and outcome of subclinical pituitary adenoma apoplexy. J Clin Neurosci 16(10):1273–1275PubMedCrossRef Zhang F, Chen J, Lu Y, Ding X (2009) Manifestation, management and outcome of subclinical pituitary adenoma apoplexy. J Clin Neurosci 16(10):1273–1275PubMedCrossRef
62.
go back to reference Sivakumar W, Chamoun R, Nguyen V, Couldwell WT (2011) Ph.D. Incidental pituitary adenomas. Neurosurg Focus 31(6):18CrossRef Sivakumar W, Chamoun R, Nguyen V, Couldwell WT (2011) Ph.D. Incidental pituitary adenomas. Neurosurg Focus 31(6):18CrossRef
Metadata
Title
The role of intervention timing and treatment modality in visual recovery following pituitary apoplexy: a systematic review and meta-analysis
Authors
Nolan J. Brown
Saarang Patel
Julian Gendreau
Mickey E. Abraham
Publication date
06-11-2024
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 3/2024
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-024-04717-z

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
 

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Register your interest now

Advances in Alzheimer's

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Learn more